Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

被引:140
作者
Tozzi, V
Balestra, P
Galgani, S
Narciso, P
Ferri, F
Sebastiani, G
D'Amato, C
Affricano, C
Pigorini, F
Pau, FM
De Felici, A
Benedetto, A
机构
[1] IRCCS Lazzaro Spallanzani, Div Infect Dis 2, Dept Infect Dis, I-00149 Rome, Italy
[2] IRCCS Lazzaro Spallanzani, Psychol Serv, I-00149 Rome, Italy
[3] IRCCS Lazzaro Spallanzani, Virol Lab, I-00149 Rome, Italy
[4] IRCCS Lazzaro Spallanzani, Clin Pathol Lab, I-00149 Rome, Italy
[5] San Camillo Hosp, Dept Neurosci, Rome, Italy
[6] C Forlanini Hosp, Dept Nucl Med, Rome, Italy
[7] Univ La Sapienza, Dept Stat, Rome, Italy
关键词
AIDS dementia complex; highly active antiretroviral therapy; HIV-1; neurocognitive impairment; protease inhibitors;
D O I
10.1097/00002030-199910010-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To determine whether highly active antiretroviral therapy (HAART) is effective in HIV-associated neurocognitive impairment. Design: An open label, prospective, observational study. Methods: Since April 1996, 116 patients with advanced HIV infection, reverse transcriptase inhibitor (nRTI) experienced but protease inhibitor (PI) naive, were screened for the presence of neurocognitive impairment. Ninety patients with confounding neurological illness, opportunistic infections or drug abuse were excluded. The remaining 26 patients underwent comprehensive neuropsychological testing, and laboratory measures before, after 6 and after 15 months of treatment with one PI plus two nRTI. Results: The prevalence of neurocognitive impairment decreased from 80.8% (baseline) to 50.0% (P < 0.05) (sixth month) and to 21.7% (P < 0.001) (15th month). Among the functions explored, the impairment of concentration and speed of mental processing decreased from 65.4 to 21.7% (P < 0.01) and of memory impairment from 50 to 8.7% (P < 0.01). Comparing baseline with the sixth and 15th month raw scores, a statistically significant improvement was seen in measures exploring concentration and speed of mental processing (P < 0.05), mental flexibility (P < 0.05), memory (P < 0.05), fine motor functions (P < 0.05) and visuospatial and constructional abilities (P < 0.01). After 6 months of HAART patients with a normal neuropsychological examination had lower mean plasma viraemia (2.95 versus 3.97 log copies/ml, P < 0.05) and greater mean log plasma HIV RNA changes from baseline (-1.84 versus -0.83 log copies/ml, P < 0.05) than neuropsychologically impaired subjects. Conclusion: HAART produces a positive and sustained effect on neurocognitive impairment in HIV-infected patients. A reduction of plasma viral load was associated with the regression of neuropsychological test abnormalities. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:1889 / 1897
页数:9
相关论文
共 26 条
[1]   TEMPORAL TRENDS IN THE INCIDENCE OF HTV-1-RELATED NEUROLOGIC DISEASES - MULTICENTER AIDS COHORT STUDY, 1985-1992 [J].
BACELLAR, H ;
MUNOZ, A ;
MILLER, EN ;
COHEN, BA ;
BESLEY, D ;
SELNES, OA ;
BECKER, JT ;
MCARTHUR, JC .
NEUROLOGY, 1994, 44 (10) :1892-1900
[2]  
BREW BJ, 1997, PATHOGENESIS TREATME, P14
[3]  
*CDCP, 1993, MMWR-MORBID MORTAL W, V41, P1
[4]  
CUNNINGHAM P, 1998, 12 WORLD AIDS C GEN
[5]  
Eggers C., 1998, Journal of Neurovirology, V4, P348
[6]   Antiretroviral drugs and the central nervous system [J].
Enting, RH ;
Hoetelmans, RMW ;
Lange, JMA ;
Burger, DM ;
Beijnen, JH ;
Portegies, P .
AIDS, 1998, 12 (15) :1941-1955
[7]   Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function [J].
Ferrando, S ;
van Gorp, W ;
McElhiney, M ;
Goggin, K ;
Sewell, M ;
Rabkin, J .
AIDS, 1998, 12 (08) :F65-F70
[8]   HIV-protease inhibitors [J].
Flexner, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1281-1292
[9]  
HAMMER SM, 1997, NEW ENGL J MED, V337, P723
[10]   EPIDEMIOLOGY OF HUMAN-IMMUNODEFICIENCY-VIRUS ENCEPHALOPATHY IN THE UNITED-STATES [J].
JANSSEN, RS ;
NWANYANWU, OC ;
SELIK, RM ;
STEHRGREEN, JK .
NEUROLOGY, 1992, 42 (08) :1472-1476